title: Soluble intercellular adhesion molecule-1 in melanoma patients treated with liposomes containing muramyl tripeptide.
authors.forename: D
authors.initials: D
authors.lastname: Favaro
authors.forename: M
authors.initials: M
authors.lastname: Santarosa
authors.forename: M
authors.initials: M
authors.lastname: Quaia
authors.forename: A
authors.initials: A
authors.lastname: Spada
authors.forename: A
authors.initials: A
authors.lastname: Freschi
authors.forename: R
authors.initials: R
authors.lastname: Talmini
authors.forename: E
authors.initials: E
authors.lastname: Galligioni
mesh_terms: D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D008081:Liposomes; D008545:Melanoma / Q000097:blood*; D012878:Skin Neoplasms / Q000097:blood*
chemical_list: D016207:Cytokines; D008081:Liposomes; D018799:Intercellular Adhesion Molecule-1; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C035104:muramylNAc-Ala-isoGln-Lys-tripeptide